SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-345733
Filing Date
2012-08-09
Accepted
2012-08-09 09:02:03
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d352691d10q.htm 10-Q 503406
2 EX-31.1 d352691dex311.htm EX-31.1 10176
3 EX-31.2 d352691dex312.htm EX-31.2 10163
4 EX32 d352691dex32.htm EX-32 7826
11 GRAPHIC g352691tx20_image.jpg GRAPHIC 102707
  Complete submission text file 0001193125-12-345733.txt   3341821

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT halo-20120630.xml EX-101.INS 422095
6 XBRL TAXONOMY EXTENSION SCHEMA halo-20120630.xsd EX-101.SCH 31361
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE halo-20120630_cal.xml EX-101.CAL 36711
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE halo-20120630_def.xml EX-101.DEF 79452
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE halo-20120630_lab.xml EX-101.LAB 219056
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE halo-20120630_pre.xml EX-101.PRE 153910
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 121018700
SIC: 2836 Biological Products, (No Diagnostic Substances)